Creative Medical Technology Stock Analysis
| CELZ Stock | USD 2.08 0.06 2.97% |
IPO Date 6th of November 2015 | 200 Day MA 2.7081 | 50 Day MA 2.2266 | Beta 2.067 |
Net Debt To EBITDA is likely to rise to 1.00 in 2026, despite the fact that Net Debt is likely to grow to (5.1 M). With a high degree of financial leverage come high-interest payments, which usually reduce Creative Medical's Earnings Per Share (EPS).
Debt Ratio | First Reported 2010-12-31 | Previous Quarter 1.26 | Current Value 1.2 | Quarterly Volatility 196.82975164 |
Creative Medical Technology is overvalued with Real Value of 1.94 and Target Price of 20.0. The main objective of Creative Medical stock analysis is to determine its intrinsic value, which is an estimate of what Creative Medical Technology is worth, separate from its market price. There are two main types of Creative Medical's stock analysis: fundamental analysis and technical analysis.
The Creative Medical stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Creative Medical is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. Creative Stock trading window is adjusted to America/New York timezone.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Creative Medical Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. Creative Stock Analysis Notes
The company has price-to-book (P/B) ratio of 1.32. Some equities with similar Price to Book (P/B) outperform the market in the long run. Creative Medical Tec recorded a loss per share of 2.84. The entity last dividend was issued on the 3rd of February 2020. The firm had 1:10 split on the 12th of June 2023. Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona. Creative Medical operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people. For more info on Creative Medical Technology please contact Timothy Warbington at 480 399 2822 or go to https://www.creativemedicaltechnology.com.Creative Medical Tec Investment Alerts
| Creative Medical Tec generated a negative expected return over the last 90 days | |
| Creative Medical Tec has high historical volatility and very poor performance | |
| Creative Medical Tec has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 11 K. Net Loss for the year was (5.49 M) with profit before overhead, payroll, taxes, and interest of 3.6 K. | |
| Creative Medical Technology currently holds about 22.86 M in cash with (5.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.62. | |
| Latest headline from finance.yahoo.com: Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 in the Treatment of Chronic Lower Back Pain |
Creative Largest EPS Surprises
Earnings surprises can significantly impact Creative Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-05-12 | 2023-03-31 | -0.1 | -0.07 | 0.03 | 30 | ||
2022-05-13 | 2022-03-31 | -0.14 | -0.18 | -0.04 | 28 | ||
2022-08-12 | 2022-06-30 | -0.15 | -0.2 | -0.05 | 33 |
Creative Medical Environmental, Social, and Governance (ESG) Scores
Creative Medical's ESG score is a quantitative measure that evaluates Creative Medical's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Creative Medical's operations that may have significant financial implications and affect Creative Medical's stock price as well as guide investors towards more socially responsible investments.
Creative Stock Institutional Investors
| Shares | Td Waterhouse Canada Inc | 2025-06-30 | 1.0 | Org Partners Llc | 2025-06-30 | 0.0 | Armistice Capital, Llc | 2025-06-30 | 0.0 | Hrt Financial Llc | 2025-06-30 | 0.0 | Geode Capital Management, Llc | 2025-06-30 | 20.9 K | Vanguard Group Inc | 2025-06-30 | 17.6 K | Northern Trust Corp | 2025-06-30 | 11.7 K | Citadel Advisors Llc | 2025-06-30 | 11.1 K | Hanson Mcclain Inc | 2025-06-30 | 4 K | Ameritas Advisory Services, Llc | 2025-06-30 | 2.3 K | Advisor Group Holdings, Inc. | 2025-06-30 | 1.1 K |
Creative Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 7.27 M.Creative Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.03) | (1.08) | |
| Return On Capital Employed | (0.82) | (0.86) | |
| Return On Assets | (0.74) | (0.78) | |
| Return On Equity | (0.78) | (0.82) |
Management Efficiency
Creative Medical Tec has return on total asset (ROA) of (0.5968) % which means that it has lost $0.5968 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9814) %, meaning that it created substantial loss on money invested by shareholders. Creative Medical's management efficiency ratios could be used to measure how well Creative Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.08 in 2026. Return On Capital Employed is likely to drop to -0.86 in 2026. At this time, Creative Medical's Total Assets are fairly stable compared to the past year. Total Current Assets is likely to rise to about 7.4 M in 2026, whereas Non Current Assets Total are likely to drop slightly above 422 K in 2026.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 4.93 | 5.17 | |
| Tangible Book Value Per Share | 4.51 | 4.74 | |
| Enterprise Value Over EBITDA | 0.40 | 0.42 | |
| Price Book Value Ratio | 0.62 | 0.65 | |
| Enterprise Value Multiple | 0.40 | 0.42 | |
| Price Fair Value | 0.62 | 0.65 | |
| Enterprise Value | -2.3 M | -2.4 M |
The decision-making processes within Creative Medical are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Technical Drivers
As of the 4th of February, Creative Medical shows the mean deviation of 4.57, and Risk Adjusted Performance of (0.13). Creative Medical Tec technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Creative Medical Tec Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Creative Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Creative Medical Tec. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Creative Medical Tec Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Creative Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Creative Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Creative Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Creative Medical Outstanding Bonds
Creative Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Creative Medical Tec uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Creative bonds can be classified according to their maturity, which is the date when Creative Medical Technology has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Creative Medical Predictive Daily Indicators
Creative Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Creative Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Creative Medical Forecast Models
Creative Medical's time-series forecasting models are one of many Creative Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Creative Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Creative Medical Tec Debt to Cash Allocation
As Creative Medical Technology follows its natural business cycle, the capital allocation decisions will not magically go away. Creative Medical's decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors.
Creative Medical Technology currently holds 14.19 K in liabilities. Creative Medical Tec has a current ratio of 57.7, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Creative Medical's use of debt, we should always consider it together with its cash and equity.Creative Medical Total Assets Over Time
Creative Medical Assets Financed by Debt
The debt-to-assets ratio shows the degree to which Creative Medical uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.Creative Medical Debt Ratio | 120.0 |
Creative Medical Corporate Bonds Issued
Creative Net Debt
About Creative Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Creative Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Creative shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Creative Medical. By using and applying Creative Stock analysis, traders can create a robust methodology for identifying Creative entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (574.32) | (545.60) | |
| Operating Profit Margin | (600.49) | (570.47) | |
| Net Loss | (574.32) | (545.60) | |
| Gross Profit Margin | 0.54 | 0.35 |
Current Creative Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Creative analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Creative analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Consensus | # of Analysts | |
| 20.0 | Buy | 1 | Odds |
Most Creative analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Creative stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Creative Medical Tec, talking to its executives and customers, or listening to Creative conference calls.
Creative Stock Analysis Indicators
Creative Medical Technology stock analysis indicators help investors evaluate how Creative Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Creative Medical shares will generate the highest return on investment. By understating and applying Creative Medical stock analysis, traders can identify Creative Medical position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 3.5 M | |
| Common Stock Shares Outstanding | 1.5 M | |
| Total Stockholder Equity | 6.3 M | |
| Total Cashflows From Investing Activities | 6.3 M | |
| Quarterly Earnings Growth Y O Y | 3.589 | |
| Cash And Short Term Investments | 5.9 M | |
| Cash | 5.9 M | |
| Accounts Payable | 273.5 K | |
| Net Debt | -5.9 M | |
| 50 Day M A | 2.2266 | |
| Total Current Liabilities | 327.6 K | |
| Other Operating Expenses | 5.8 M | |
| Non Current Assets Total | 533.8 K | |
| Non Currrent Assets Other | 3281.00 | |
| Stock Based Compensation | 36.6 K |
Additional Tools for Creative Stock Analysis
When running Creative Medical's price analysis, check to measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.